• FDA Adverse Event Data Release May Mean More Lawsuits
  • March 10, 2017 | Authors: Joanne S. Hawana; Daniel Joseph Herling
  • Law Firm: Mintz Levin Cohn Ferris Glovsky Popeo P.C. - Boston Office
  • Law 360, New York (January 18, 2017, 11:47 AM EST) - The recent release of a large cache of historical data on reported adverse events, along with government plans to make raw data available on an ongoing basis, may have ripple effects on consumer class actions and other types of lawsuits filed against cosmetic, food and supplement manufacturers and retailers.